| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |